# sildenafil CITRATE

NDC: 59651-420
Generic name: sildenafil CITRATE
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: POWDER, FOR SUSPENSION
Routes: ORAL
Marketing started: 20221223

FDA application: ANDA214773

## Active ingredients

- SILDENAFIL CITRATE: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59651-420"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59651-420
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b60b4fdc-9b78-45e6-8438-8a30f83ed976